Total Payments
$156,306
2024 Payments
$6,972
Companies
45
Transactions
1,141
Medicare Patients
18,038
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$84,600 (54.1%)
Consulting$30,175 (19.3%)
Food & Beverage$24,076 (15.4%)
Travel$17,059 (10.9%)
Education$395.23 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $69,200 | 34 | 44.3% |
| Consulting Fee | $30,175 | 14 | 19.3% |
| Food and Beverage | $24,076 | 1,024 | 15.4% |
| Travel and Lodging | $17,059 | 48 | 10.9% |
| Honoraria | $13,750 | 4 | 8.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,650 | 1 | 1.1% |
| Education | $395.23 | 16 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $48,773 | 199 | $0 (2024) |
| PFIZER INC. | $30,402 | 117 | $0 (2024) |
| DERMIRA, INC. | $20,344 | 20 | $0 (2021) |
| Amgen Inc. | $12,938 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $11,020 | 86 | $0 (2024) |
| Allergan, Inc. | $7,190 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $6,070 | 81 | $0 (2024) |
| LEO Pharma Inc. | $3,766 | 111 | $0 (2024) |
| UCB, Inc. | $3,053 | 36 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $1,749 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,972 | 213 | UCB, Inc. ($2,439) |
| 2023 | $6,927 | 110 | LEO Pharma Inc. ($2,347) |
| 2022 | $2,019 | 90 | ABBVIE INC. ($352.23) |
| 2021 | $3,832 | 94 | Novartis Pharmaceuticals Corporation ($2,084) |
| 2020 | $10,663 | 95 | AbbVie Inc. ($7,447) |
| 2019 | $40,884 | 154 | DERMIRA, INC. ($20,324) |
| 2018 | $44,812 | 196 | AbbVie, Inc. ($16,579) |
| 2017 | $40,197 | 189 | PFIZER INC. ($11,042) |
All Payment Transactions
1,141 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.45 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.24 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Immunology | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.83 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.47 | General |
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $23.31 | General |
| Category: Immunology | ||||||
| 11/18/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $10.56 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.62 | General |
| Category: Immunology | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 4,574 | 10,130 | $2.9M | $702,123 |
| 2022 | 30 | 5,015 | 11,950 | $3.8M | $874,877 |
| 2021 | 23 | 4,318 | 6,371 | $1.4M | $338,721 |
| 2020 | 18 | 4,131 | 5,667 | $1.0M | $236,958 |
Total Patients
18,038
Total Services
34,118
Medicare Billing
$2.2M
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 63 | 1,143 | $888,429 | $220,349 | 24.8% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 67 | 1,204 | $469,891 | $155,019 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,315 | 1,605 | $424,812 | $85,924 | 20.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 558 | 622 | $209,938 | $43,834 | 20.9% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 63 | 1,107 | $128,878 | $32,090 | 24.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 59 | 209 | $117,743 | $29,402 | 25.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 455 | 513 | $153,899 | $29,321 | 19.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 613 | 720 | $141,902 | $23,030 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 131 | $48,775 | $11,200 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 190 | 190 | $62,963 | $10,733 | 17.0% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 50 | 149 | $35,386 | $9,012 | 25.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 398 | 1,807 | $36,295 | $8,162 | 22.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 11 | 22 | $25,780 | $6,741 | 26.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 52 | 61 | $32,457 | $6,589 | 20.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 175 | 187 | $30,602 | $6,553 | 21.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 85 | 113 | $17,342 | $3,847 | 22.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 33 | 35 | $17,396 | $3,201 | 18.4% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 50 | 63 | $11,965 | $3,026 | 25.3% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 44 | 45 | $9,346 | $2,321 | 24.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 22 | 24 | $10,428 | $2,262 | 21.7% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 48 | 48 | $13,026 | $2,022 | 15.5% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 16 | 16 | $5,592 | $1,461 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $6,387 | $1,346 | 21.1% |
| 69100 | Biopsy of ear | Office | 2023 | 27 | 27 | $7,709 | $1,298 | 16.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 25 | 25 | $5,482 | $1,164 | 21.2% |
About Dr. Keith Loven, MD
Dr. Keith Loven, MD is a Dermatology healthcare provider based in Goodlettsville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1235116518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Loven, MD has received a total of $156,306 in payments from pharmaceutical and medical device companies, with $6,972 received in 2024. These payments were reported across 1,141 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($69,200).
As a Medicare-enrolled provider, Loven has provided services to 18,038 Medicare beneficiaries, totaling 34,118 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Goodlettsville, TN
- Active Since 12/28/2005
- Last Updated 07/15/2010
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1235116518
Products in Payments
- Humira (Biological) $29,333
- EUCRISA (Drug) $28,960
- QBREXZA (Drug) $20,317
- Enbrel (Biological) $10,056
- SKYRIZI (Biological) $8,394
- Skyrizi (Biological) $7,676
- Tremfya (Drug) $4,998
- COSENTYX (Biological) $3,749
- TREMFYA (Drug) $2,617
- ACZONE (Drug) $2,516
- Bimzelx (Biological) $2,190
- ONEXTON (Drug) $1,694
- EPIDUO FORTE (Drug) $1,231
- TALTZ (Drug) $1,169
- ADBRY (Biological) $1,133
- VTAMA (Drug) $1,082
- DUPIXENT (Biological) $1,049
- Sotyktu (Drug) $554.81
- ENSTILAR (Drug) $492.73
- COSENTYX (Drug) $487.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.